Researchers reviewed data from more than 1,300 patients who underwent both CCTA and TEE after undergoing LAAO. The two modalities were comparable in many ways, but cardiac CT was linked to a few key benefits.

SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

The issue, associated with calcification, can make these devices less effective over time. The Heart Rhythm Society shared a detailed analysis of the situation.

Some patients feel anxiety due to the risk of being shocked. Others have device recalls and/or cybersecurity threats on their mind.

Stereotaxis has received FDA clearance for the first mapping catheter of its kind. The company emphasized that this is just the first of many robotically navigated devices it is working to bring to the U.S. market.

Researchers had thought 2-HOBA might reduce the risk of AFib recurrence after catheter ablation procedures. What they found, however, was that treatment with the compound was actually harmful for patients instead of helpful.